W. Bryan Hill - 23 Sep 2024 Form 4 Insider Report for ALKAMI TECHNOLOGY, INC. (ALKT)

Role
Chief Financial Officer
Signature
/s/ Douglas A. Linebarger, as Attorney-in-Fact for W. Bryan Hill
Issuer symbol
ALKT
Transactions as of
23 Sep 2024
Net transactions value
-$2,872,567
Form type
4
Filing time
25 Sep 2024, 17:39:21 UTC
Previous filing
06 Sep 2024
Next filing
20 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKT Common Stock Options Exercise $128,808 +55,046 +12% $2.34 526,449 23 Sep 2024 Direct
transaction ALKT Common Stock Sale $1,716,670 -55,046 -10% $31.19 471,403 23 Sep 2024 Direct F1, F2
transaction ALKT Common Stock Options Exercise $105,192 +44,954 +9.5% $2.34 516,357 24 Sep 2024 Direct
transaction ALKT Common Stock Sale $1,389,897 -44,954 -8.7% $30.92 471,403 24 Sep 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKT Stock Option (Right to Buy) Options Exercise $0 -55,046 -14% $0.000000 344,954 23 Sep 2024 Common Stock 55,046 $2.34 Direct F4
transaction ALKT Stock Option (Right to Buy) Options Exercise $0 -44,954 -13% $0.000000 300,000 24 Sep 2024 Common Stock 44,954 $2.34 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $30.77 to $31.72. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $30.68 to $31.29. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The shares subject to the option are fully vested and exercisable.